NCT00421122View on ClinicalTrials.gov

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

November 30, 2007

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

budesonide/formoterol (Symbicort)

inhalation therapy

DRUG

budesonide (Pulmicort)

inhalation

DRUG

terbutaline sulfate (Bricasol)

inhalation therapy

Trial Locations (8)

Unknown

Research Site, Beijing

Research Site, Guangzhou

Research Site, Nanjing

Research Site, Shenyang

Research Site, Shanghai

Research Site, Xi’an

Research Site, Chengdu

Research Site, Hangzhou

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY